These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32681396)

  • 21. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
    Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
    Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.
    Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ; ; ;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S131-5. PubMed ID: 26315678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
    Arcani R; Bertin D; Bardin N; Mazodier K; Jean R; Suchon P; Venton G; Daumas A; Jean E; Villani P; Kaplanski G; Jarrot PA
    Rheumatology (Oxford); 2021 Sep; 60(9):4074-4084. PubMed ID: 33404653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
    Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases.
    Fraziano M; Montesano C; Lombardi VR; Sammarco I; De Pisa F; Mattei M; Valesini G; Pittoni V; Colizzi V
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):491-6. PubMed ID: 8679304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis.
    Lakota K; Thallinger GG; Sodin-Semrl S; Rozman B; Ambrozic A; Tomsic M; Praprotnik S; Cucnik S; Mrak-Poljsak K; Ceribelli A; Cavazzana I; Franceschini F; Vencovsky J; Czirják L; Varjú C; Steiner G; Aringer M; Stamenkovic B; Distler O; Matucci-Cerinic M; Kveder T
    Arthritis Res Ther; 2012 Jan; 14(1):R2. PubMed ID: 22226402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
    Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
    Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.
    Esen BA; Yılmaz G; Uzun S; Ozdamar M; Aksözek A; Kamalı S; Türkoğlu S; Gül A; Ocal L; Aral O; Inanç M
    Rheumatol Int; 2012 Jan; 32(1):79-83. PubMed ID: 20661740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis.
    Fujimoto M; Shimozuma M; Yazawa N; Kubo M; Ihn H; Sato S; Tamaki T; Kikuchi K; Tamaki K
    Ann Rheum Dis; 1997 Nov; 56(11):667-70. PubMed ID: 9462169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
    Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
    Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
    Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.
    Ricchiuti V; Briand JP; Meyer O; Isenberg DA; Pruijn G; Muller S
    Clin Exp Immunol; 1994 Mar; 95(3):397-407. PubMed ID: 7511075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
    Ricchiuti V; Isenberg D; Muller S
    J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death.
    Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
    J Immunol; 2006 May; 176(10):6277-85. PubMed ID: 16670339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis.
    Martel ME; Leurs A; Launay D; Behal H; Chepy A; Collet A; Sanges S; Hachulla E; Dubucquoi S; Dauchet L; Sobanski V
    Autoimmun Rev; 2024 May; 23(5):103536. PubMed ID: 38555075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.